Nicholas T Bott1, Erica T Johnson2, Norbert Schuff3, Nicholas Galifianakis4, Trishna Subas2, Jessica Pollock3, Peter Pressman2, Joel H Kramer2, Katherine L Possin2. 1. Department of Neurology, Memory and Aging Center, University of California, San Francisco, USA. Electronic address: nbott@stanford.edu. 2. Department of Neurology, Memory and Aging Center, University of California, San Francisco, USA. 3. Department of Radiology and Biomedical Imaging, University of California, San Francisco, USA; Department of Veterans Affairs Medical Center, San Francisco, CA, USA. 4. Parkinson's Disease Research, Education, and Clinical Center, San Francisco Veteran's Affairs Medical Center, San Francisco, USA.
Abstract
BACKGROUND: We examined the sensitivity of different executive function measures for detecting deficits in Parkinson's disease patients without dementia. METHODS: Twenty-one non-demented PD subjects and 21 neurologically healthy controls were administered widely used clinical executive functioning measures as well as the NIH EXAMINER battery, which produces Cognitive Control, Working Memory, and Verbal Fluency scores, along with an overall Executive Composite score, using psychometrically matched scales. RESULTS: No significant differences between groups were observed on widely used clinical measures. The PD patients scored lower than controls on the EXAMINER Executive Composite, Cognitive Control, and Working Memory Scores. CONCLUSIONS: The NIH EXAMINER Executive Composite and Cognitive Control Scores are sensitive measures of executive dysfunction in non-demented PD, and may be more sensitive than several widely used measures. Results highlight the importance of careful test selection when evaluating for mild cognitive impairment in PD.
BACKGROUND: We examined the sensitivity of different executive function measures for detecting deficits in Parkinson's diseasepatients without dementia. METHODS: Twenty-one non-demented PD subjects and 21 neurologically healthy controls were administered widely used clinical executive functioning measures as well as the NIH EXAMINER battery, which produces Cognitive Control, Working Memory, and Verbal Fluency scores, along with an overall Executive Composite score, using psychometrically matched scales. RESULTS: No significant differences between groups were observed on widely used clinical measures. The PDpatients scored lower than controls on the EXAMINER Executive Composite, Cognitive Control, and Working Memory Scores. CONCLUSIONS: The NIH EXAMINER Executive Composite and Cognitive Control Scores are sensitive measures of executive dysfunction in non-demented PD, and may be more sensitive than several widely used measures. Results highlight the importance of careful test selection when evaluating for mild cognitive impairment in PD.
Authors: Mark Broeders; Daan C Velseboer; Rob de Bie; Johannes D Speelman; Dino Muslimovic; Bart Post; Rob de Haan; Ben Schmand Journal: J Int Neuropsychol Soc Date: 2013-04-02 Impact factor: 2.892
Authors: D Aarsland; K Bronnick; C Williams-Gray; D Weintraub; K Marder; J Kulisevsky; D Burn; P Barone; J Pagonabarraga; L Allcock; G Santangelo; T Foltynie; C Janvin; J P Larsen; R A Barker; M Emre Journal: Neurology Date: 2010-09-21 Impact factor: 9.910
Authors: Katherine L Possin; Gail A Kang; Christine Guo; Eric M Fine; Andrew J Trujillo; Caroline A Racine; Reva Wilheim; Erica T Johnson; Jennifer L Witt; William W Seeley; Bruce L Miller; Joel H Kramer Journal: Mov Disord Date: 2013-07-11 Impact factor: 10.338
Authors: S Christine You; Michael D Geschwind; Sharon J Sha; Alexandra Apple; Gabriella Satris; Kristie A Wood; Erica T Johnson; Jonathan Gooblar; Jeanne S Feuerstein; Steven Finkbeiner; Gail A Kang; Bruce L Miller; Christopher P Hess; Joel H Kramer; Katherine L Possin Journal: Mov Disord Date: 2013-12-27 Impact factor: 10.338